3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Neoplasm Metastasis
11
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Neoplasms
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Glioblastoma
2
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Hormone Receptor Positive Breast Cancer
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Interventions
pazopanib
5
Doxorubicin
3
Bevacizumab
3
carotuximab
2
Sorafenib
2
Radiotherapy, Conformal
2
Paclitaxel
2
Gemcitabine
2
tremelimumab
1
trebananib
1
temsirolimus
1
talimogene laherparepvec
1
romidepsin
1
regorafenib
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
cixutumumab
1
Watchful Waiting
1
Vascular Endothelial Growth Factor A
1
TTI-621
1
Sunitinib
1
Sirolimus
1
Razoxane
1
Observation
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
HhAntag691
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangiosarcoma
×
abemaciclib
×
Clear all
No trials found.